London School of Hygiene & Tropical Medicine, London, UK.
Ophthalmology. 2012 May;119(5):1033-40. doi: 10.1016/j.ophtha.2011.11.002. Epub 2012 Feb 18.
To estimate the prevalence and causes of blindness in Chiapas, Mexico, and to assess the feasibility of using the Rapid Assessment of Avoidable Blindness framework to estimate diabetic retinopathy (DR) prevalence.
A cross-sectional population-based survey.
Sixty-six clusters of 50 people 50 years of age or older were selected by probability proportionate to size sampling. Households within clusters were selected through compact segment sampling.
Participants underwent visual acuity (VA) screening and diagnosis of cause of visual impairment by an ophthalmologist. Participants were classed as having diabetes if they had a previous diagnosis of diabetes, were receiving treatment for glucose control, or had a random blood glucose level of more than 200 mg/dl. Participants with diabetes were assessed for DR using dilated clinical examination (direct and indirect ophthalmoscope) and 1 dilated digital fundus photograph per eye (graded by an ophthalmologist during the survey and regraded by a retinal specialist-"reference standard") following the Scottish DR grading protocol.
Prevalence of blindness (VA <20/400 in the best eye with available correction) and DR.
Three thousand three hundred subjects were selected, of whom 2864 (87%) were examined. The estimated prevalence of bilateral blindness was 2.3% (95% confidence interval [CI], 1.7%-2.9%). Cataract was the leading cause of bilateral blindness (63%), followed by posterior segment diseases (24%), which included DR (8% of blindness). The prevalence of diabetes was 21% (19.5%-23.1%). Among participants with diabetes, the prevalence of DR (in at least 1 eye) was 38.9% (95% CI, 33.7%-44.1%). The prevalence of sight-threatening DR (STDR; defined as proliferative DR, referable maculopathy, or both) was 21.0% (95% CI, 16.7%-25.3%). Agreement with the reference standard was good for any retinopathy and STDR for the clinical examination (κ = 0.80 and 0.79, respectively) and the photograph graded during the survey (κ = 0.80 and 0.82, respectively).
The prevalence of diabetes and DR in Chiapas was high. Including the DR component was possible, but added considerably to the cost and complexity of the survey, and so would be warranted only if a high prevalence of diabetes is expected and if resources and time permit.
估计墨西哥恰帕斯州的失明患病率和失明原因,并评估使用快速评估可避免盲法(Rapid Assessment of Avoidable Blindness,简称 RAAB)框架估计糖尿病视网膜病变(diabetic retinopathy,简称 DR)患病率的可行性。
一项基于人群的横断面研究。
通过概率比例抽样法选择了 66 个 50 岁及以上人群的聚类,每个聚类包含 50 人。通过紧凑段抽样选择聚类内的家庭。
参与者接受视力(visual acuity,简称 VA)筛查和眼科医生对视力损害原因的诊断。如果参与者有糖尿病既往诊断、正在接受血糖控制治疗或随机血糖水平超过 200mg/dl,则将其归类为患有糖尿病。对患有糖尿病的参与者进行 DR 评估,方法是通过散瞳临床检查(直接和间接检眼镜)和每只眼 1 张散瞳数字眼底照片(在调查期间由眼科医生进行评估,并由视网膜专家进行重新分级-“参考标准”),并按照苏格兰 DR 分级方案进行评估。
双眼盲(最佳矫正视力<20/400)和 DR 的患病率。
共选择了 3300 名受试者,其中 2864 名(87%)接受了检查。双侧盲的估计患病率为 2.3%(95%置信区间[CI],1.7%-2.9%)。白内障是双侧盲的主要原因(占 63%),其次是后段疾病(占 24%),其中包括 DR(占失明的 8%)。糖尿病的患病率为 21%(19.5%-23.1%)。在患有糖尿病的参与者中,DR(至少 1 只眼)的患病率为 38.9%(95%CI,33.7%-44.1%)。威胁视力的 DR(定义为增生性 DR、可致盲黄斑病变或两者兼有)的患病率为 21.0%(95%CI,16.7%-25.3%)。临床检查和调查期间分级的照片对任何视网膜病变和威胁视力的 DR 的分级与参考标准的一致性良好(κ 值分别为 0.80 和 0.79)。
恰帕斯州的糖尿病和 DR 患病率较高。纳入 DR 部分是可能的,但会大大增加调查的成本和复杂性,因此只有在预计糖尿病患病率较高且资源和时间允许的情况下才是合理的。